Systematic Review on the Antibacterial Resistance of Vibrio Cholerae
DOI:
https://doi.org/10.56919/usci.1122.009Keywords:
Vibrio cholerae, Antibacterial Resistance, Mutation, Systematic ReviewAbstract
Background: Vibrio cholerae is the causative agent of cholera illness. Antibacterial resistance of V. cholerae is frequently experienced due to the environmental pressure from human and animal overuse and misuse of antibacterials. Among such antibacterials include Tetracycline, Chloramphenicol, Furazolidone, Ampicillin, and Trimethoprim-Cotrimoxazole as used against V. cholerae O1, O139 and non O1, O139 strains.
Objectives: This systematic review was aimed at providing an overview of Antibacterial resistant strains of Vibrio cholerae in terms of year, location and factors responsible for the resistance.
Material and Method: Systematic Electronic database search of PubMed (NCBI) by means of the key terms MeSH “Antimicrobial resistance of Vibrio cholerae” between the period of January 2000 to October 2018 was used.
Results: From the findings it showed that many factors are responsible for Antibacterial resistance of Vibrio cholerae which include genetic composition, mutation, enzymes. Also V. cholerae, both O1, O139, environmental and non O1/ non O139 such as V. anginiloticus, paraheamolytcus were incriminated in transferring resistance genes from one another. Antimimicrobial Susceptibility Testing phenotypic and Polymerase Chain Reaction (PCR) molecular procedure were employed in detecting the resistance and equally the use of Global Antimicrobial Surveillance System (GLASS) and Centre for Disease control (CDC) AR threat report 2019 was used successfully in the management of Vibrio cholerae epidemic.
Conclusions: Drug-resistant Vibrio cholarae is a problem that needs to be dealt with as soon as possible
References
Akoachere, J.-F. T. K., Masalla, T. N., & Njom, H. A. (2013). Multidrug resistant toxigenic Vibrio cholerae O1 is persistent in water sources in New Bell-Douala, Cameroon. BMC Infectious Diseases, 13, 366. https://doi.org/10.1186/1471-2334-13-366
Bier, N., Schwartz, K., Guerra, B., & Strauch, E. (2015). Survey on antimicrobial resistance patterns in Vibrio vulnificus and Vibrio cholerae non-O1/non-O139 in Germany reveals carbapenemase-producing Vibrio cholerae in coastal waters. Frontiers in Microbiology, 6, 1179. https://doi.org/10.3389/fmicb.2015.0117
Campos, L. C., Zahner, V., Avelar, K. E. S., Alves, R. M., Pereira, D. S. G., Vital, B. J. M. and Karaolis, D. K. R. (2004). Genetic diversity and antibiotic resistance of clinical and environmental Vibrio cholerae suggests that many serogroups are reservoirs of resistance. Epidemiology and Infection, 132(5), 985-992. https://doi.org/10.1017/S0950268804002705
Dengo-Baloi, L. C., Sema-Baltazar, C. A., Manhique, L. V., Chitio, J. E., Inguane, D. L., & Langa, J. P. (2017). Antibiotics resistance in El Tor Vibrio cholerae 01 isolated during cholera outbreaks in Mozambique from 2012 to 2015. PloS One, 12(8), e0181496. https://doi.org/10.1371/journal.pone.0181496
Dixit, S. M., Johura, F.-T., Manandhar, S., Sadique, A., Rajbhandari, R. M., Mannan, S. B., … Alam, M. (2014). Cholera outbreaks (2012) in three districts of Nepal reveal clonal transmission of multi-drug resistant Vibrio cholerae O1. BMC Infectious Diseases, 14, 392.
https://doi.org/10.1186/1471-2334-14-392
Gupta, P. K., Pant, N. D., Bhandari, R., & Shrestha, P. (2018). Cholera outbreak caused by drug resistant Vibrio cholerae serogroup O1 biotype ElTor serotype Ogawa in Nepal; a cross-sectional study. Antimicrobial Resistance and Infection Control, 5, 23. https://doi.org/10.1186/s13756-016-0122-7
Ismail, H., Smith, A. M., Sooka, A., & Keddy, K. H. (2011). Genetic characterization of multidrug-resistant, extended-spectrum- beta-lactamase-producing Vibrio cholerae O1 outbreak strains, Mpumalanga, South Africa, 2008. Journal of Clinical Microbiology, 49(8), 2976-2979. https://doi.org/10.1128/JCM.00293-11
Kar, S. K., Pal, B. B., Khuntia, H. K., Achary, K. G., & Khuntia, C. P. (2015). Emergence and spread of tetracycline resistant Vibrio cholerae O1 El Tor variant during 2010 cholera epidemic in the tribal areas of Odisha, India. International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases, 33, 45-49. https://doi.org/10.1016/j.ijid.2014.12.025
Kim, H. Bin, Wang, M., Ahmed, S., Park, C. H., LaRocque, R. C., Faruque, A. S. G., … Hooper, D. C. (2010). Transferable quinolone resistance in Vibrio cholerae. Antimicrobial Agents and Chemotherapy, 54(2), 799-803. https://doi.org/10.1128/AAC.01045-09
Kitaoka, M., Miyata, S. T., Unterweger, D., & Pukatzki, S. (2011). Antibiotic resistance mechanisms of Vibrio cholerae. Journal of Medical Microbiology, 60 (4), 397-407. https://doi.org/10.1099/jmm.0.023051-0
Mala, W., Kaewkes, W., Tattawasart, U., Wongwajana, S., Faksri, K., & Chomvarin, C. (2016). SXT ELEMENT, Class 1 Integron And Multidrug-Resistance Genes Of Vibrio cholerae Isolated From Clinical And Environmental Sources In Northeast Thailand. The Southeast Asian Journal of Tropical Medicine and Public Health, 47(5), 957-966.
Marin, M. A., Thompson, C. C., Freitas, F. S., Fonseca, E. L., Aboderin, A. O., Zailani, S. B., … Vicente, A. C. P. (2013). Cholera outbreaks in Nigeria are associated with multidrug resistant atypical El Tor and non-O1/non-O139 Vibrio cholerae. PLoS Neglected Tropical Diseases, 7 (2), e2049. https://doi.org/10.1371/journal.pntd.0002049
Mechri, B., Medhioub, A., Medhioub, M. N., & Aouni, M. (2013). Genotypic diversity, antimicrobial resistance and screening of Vibrio cholerae molecular virulence markers in Vibrio alginolyticus strains recovered from a Tunisian Ruditapes decussatus hatchery. Polish Journal of Microbiology, 62(3), 263-272. https://doi.org/10.33073/pjm-2013-034
Rezaie, N., Bakhshi, B., & Najar-Peerayeh, S. (2017). Distribution of resistance genetic determinants among Vibrio cholerae isolates of 2012 and 2013 outbreaks in IR Iran. Microbial Pathogenesis, 104, 12-16. https://doi.org/10.1016/j.micpath.2017.01.005
Savel'ev, V. N., Babenyshev, B. V, Savel'eva, I. V, Vasil'eva, O. V, Guseva, L. V, Grizhebovskii, G. M., … Antonenko, A. D. (2010). Antibacterial susceptibility/resistance of Vibrio cholerae el tor clinical strains isolated in the Caucasus during the seventh cholera pandemic. Antibiotics and chemotherapy science, 55(5-6), 8-13.
Scrascia, M., Pugliese, N., Maimone, F., Mohamud, K. A., Ali, I. A., Grimont, P. A. D., & Pazzani, C. (2009). Cholera in Ethiopia in the 1990 s: epidemiologic patterns, clonal analysis, and antimicrobial resistance. International Journal of Medical Microbiology : IJMM, 299(5), 367-372. https://doi.org/10.1016/j.ijmm.2008.10.004
Singh, A. K., Haldar, R., Mandal, D., & Kundu, M. (2006). Analysis of the topology of Vibrio cholerae NorM and identification of amino acid residues involved in norfloxacin resistance. Antimicrobial Agents and Chemotherapy, 50(11), 3717-3723. https://doi.org/10.1128/AAC.00460-06
Sulca, M. A., Orozco, R., & Alvarado, D. E. (2018). Antimicrobial resistance not related to 1,2,3 integrons and Superintegron in Vibrio spp. isolated from seawater sample of Lima (Peru). Marine Pollution Bulletin, 131(Pt A), 370-377. https://doi.org/10.1016/j.marpolbul.2018.04.050
Yu, L., Zhou, Y., Wang, R., Lou, J., Zhang, L., Li, J., … Kan, B. (2012). Multiple antibiotic resistance of Vibrio cholerae serogroup O139 in China from 1993 to 2009. PloS One, 7(6), e38633. https://doi.org/10.1371/journal.pone.0038633
Zadnova, S. P., & Smirnova, N. I. (2015). Isolation Of Antibiotics Resistance Genes In Vibrio Cholerae O1 And O139 Serogroup Strains. Zhurnal mikrobiologii, epidemiologii, i immunobiologii, (3), 3-10.
Zhou, Y., Yu, L., Li, J., Zhang, L., Tong, Y., & Kan, B. (2013). Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains. International Journal of Antimicrobial Agents, 42(1), 72-75. https://doi.org/10.1016/j.ijantimicag.2013.03.004
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 UMYU Scientifica
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
